Drug interactions
Certolizumab pegol + Lisocabtagene maraleucel
Severity: Major
Certolizumab pegol and Lisocabtagene maraleucel: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Certolizumab pegol blocks TNF and causes immunosuppression, while lisocabtagene maraleucel follows lymphodepleting chemotherapy and causes prolonged cytopenias and B-cell aplasia. Together they may raise the risk of serious infection. TNF inhibition may also affect CAR-T expansion and cytokine signalling.
What this interaction means in plain words
Certolizumab pegol and Lisocabtagene maraleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Certolizumab pegol belongs to Musculoskeletal; Lisocabtagene maraleucel belongs to Oncology.
Why it happens
Additive immunosuppression from TNF blockade and CAR-T related lymphodepletion and B-cell aplasia.
What to do
Avoid starting certolizumab pegol around CAR-T infusion unless clearly needed, and consider an alternative. If it cannot be avoided, monitor closely for infection and cytopenias.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Certolizumab pegol and Lisocabtagene maraleucel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Certolizumab pegol
- Adenovirus types 4 and 7 live + Certolizumab pegol Contraindicated
- Bcg intravesical live + Certolizumab pegol Contraindicated
- Bcg vaccine live + Certolizumab pegol Contraindicated
- Certolizumab pegol + Influenza virus vaccine quadrivalent intranasal Contraindicated
- Certolizumab pegol + Measles mumps and rubella vaccine Contraindicated
- Certolizumab pegol + Measles mumps and rubella vaccine live Contraindicated
Other interactions of Lisocabtagene maraleucel
Frequently asked questions
Can I take Certolizumab pegol with Lisocabtagene maraleucel?
MediHelp rates the interaction as major. Certolizumab pegol and Lisocabtagene maraleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Certolizumab pegol blocks TNF and causes immunosuppression, while lisocabtagene maraleucel follows lymphodepleting chemotherapy and causes prolonged cytopenias and B-cell aplasia. Together they may raise the risk of serious infection. TNF inhibition may also affect CAR-T expansion and cytokine signalling.
How serious is the interaction between Certolizumab pegol and Lisocabtagene maraleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid starting certolizumab pegol around CAR-T infusion unless clearly needed, and consider an alternative. If it cannot be avoided, monitor closely for infection and cytopenias.
What other medicines interact with Certolizumab pegol?
MediHelp also lists interactions of Certolizumab pegol with, for example, Adenovirus types 4 and 7 live, Bcg intravesical live, Bcg vaccine live. The full list is on the Certolizumab pegol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.